167 related articles for article (PubMed ID: 31506552)
1. The double inhibition of PDK1 and STAT3-Y705 prevents liver metastasis in colorectal cancer.
Qin W; Tian Y; Zhang J; Liu W; Zhou Q; Hu S; Yang F; Lu L; Lu H; Cui S; Wen L; Wei S
Sci Rep; 2019 Sep; 9(1):12973. PubMed ID: 31506552
[TBL] [Abstract][Full Text] [Related]
2. Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia.
Peng F; Wang JH; Fan WJ; Meng YT; Li MM; Li TT; Cui B; Wang HF; Zhao Y; An F; Guo T; Liu XF; Zhang L; Lv L; Lv DK; Xu LZ; Xie JJ; Lin WX; Lam EW; Xu J; Liu Q
Oncogene; 2018 Feb; 37(8):1062-1074. PubMed ID: 29106390
[TBL] [Abstract][Full Text] [Related]
3. Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
Chu PC; Lin PC; Wu HY; Lin KT; Wu C; Bekaii-Saab T; Lin YJ; Lee CT; Lee JC; Chen CS
Oncogene; 2018 Jun; 37(25):3440-3455. PubMed ID: 29559746
[TBL] [Abstract][Full Text] [Related]
4. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
6. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
8. Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.
Mesci A; Taeb S; Huang X; Jairath R; Sivaloganathan D; Liu SK
World J Gastroenterol; 2014 Dec; 20(46):17376-87. PubMed ID: 25516649
[TBL] [Abstract][Full Text] [Related]
9. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
[TBL] [Abstract][Full Text] [Related]
10. LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis.
Wang H; Liu Z; Guan L; Li J; Chen S; Yu W; Lai M
Pharmacol Res; 2020 Mar; 153():104661. PubMed ID: 31982491
[TBL] [Abstract][Full Text] [Related]
11. Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer.
Qin Y; Shembrey C; Smith J; Paquet-Fifield S; Behrenbruch C; Beyit LM; Thomson BNJ; Heriot AG; Cao Y; Hollande F
Cancer Lett; 2020 Apr; 476():161-169. PubMed ID: 32105676
[TBL] [Abstract][Full Text] [Related]
12. Ferritin Light Chain (FTL) competes with long noncoding RNA Linc00467 for miR-133b binding site to regulate chemoresistance and metastasis of colorectal cancer.
Li Z; Liu J; Chen H; Zhang Y; Shi H; Huang L; Tao J; Shen R; Wang T
Carcinogenesis; 2020 Jun; 41(4):467-477. PubMed ID: 31675755
[TBL] [Abstract][Full Text] [Related]
13. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
Wang G; Gu J; Gao Y
Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
16. HNF6 promotes tumor growth in colorectal cancer and enhances liver metastasis in mouse model.
Jiang K; Jiao Y; Liu Y; Fu D; Geng H; Chen L; Chen H; Shen X; Sun L; Ding K
J Cell Physiol; 2019 Apr; 234(4):3675-3684. PubMed ID: 30256389
[TBL] [Abstract][Full Text] [Related]
17. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Shen L; Zhang G; Lou Z; Xu G; Zhang G
BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
[TBL] [Abstract][Full Text] [Related]
18. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
19. The RNA binding protein neuro-oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA stability to enhance JAK2-STAT3 signaling in CRC.
Hong YG; Xu GS; Yu GY; Zhou JD; Liu QZ; Ni JS; Yan HL; Zhang W; Hao LQ
Surg Oncol; 2019 Dec; 31():67-74. PubMed ID: 31541909
[TBL] [Abstract][Full Text] [Related]
20. Cryptotanshinone, a novel PDK 4 inhibitor, suppresses bladder cancer cell invasiveness via the mTOR/β‑catenin/N‑cadherin axis.
Kim CJ; Terado T; Tambe Y; Mukaisho KI; Kageyama S; Kawauchi A; Inoue H
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 33982789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
